Abstract
Impaired autophagic flux induces aging-related ischemia vulnerability, which is the hallmark pathology in cardiac aging. Our previous work has confirmed that the accumulation of charged multivesicular body protein 2B (CHMP2B), a subunit of the ESCRT-III complex, in the heart can impair autophagy flux. However, whether CHMP2B accumulation contributes to aging-related intolerance to ischemia/reperfusion (I/R) injury and the regulatory mechanism for CHMP2B in aged heart remain elusive. The cardiac CHMP2B level was significantly higher in aged human myocardium than that in young myocardium. Increased CHMP2B were shown to inhibit autophagic flux leading to the deterioration of MI/R injury in aged mice hearts. Interestingly, a negative correlation was observed between SIRT6 and CHMP2B expression in human heart samples. Specific activation of SIRT6 suppressed CHMP2B accumulation and ameliorated autophagy flux in aged hearts. Using myocardial-specific SIRT6 heterozygous knockout mice and recovery experiments confirmed that SIRT6 regulated myocardial CHMP2B levels. Finally, activation of SIRT6 decreased acetylation of FoxO1 to promote its transcriptional function on Atrogin-1, a muscle-specific ubiquitin ligase, which subsequently enhanced the degradation of CHMP2B by Atrogin-1. This is a novel mechanism for SIRT6 against aging-related myocardial ischemia vulnerability, particularly by preventing excessive accumulation of autophagy key factors.
Graphic Abstract
Similar content being viewed by others
References
GBD 2017 Causes of Death Collaborators. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1736–1788.
Ma, H., Wang, J., Thomas, D. P., Tong, C., Leng, L., Wang, W., et al. (2010). Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation, 122(3), 282–292.
Li, C., Mu, N., Gu, C., Liu, M., Yang, Z., Yin, Y., et al. (2020). Metformin mediates cardioprotection against aging-induced ischemic necroptosis. Aging Cell, 19(2), e13096.
Ren, J., & Zhang, Y. (2018). Targeting autophagy in aging and aging-related cardiovascular diseases. Trends in Pharmacological Sciences, 39(12), 1064–1076.
Li, X., Liu, L., Li, T., Liu, M., Wang, Y., Ma, H., et al. (2021). SIRT6 in senescence and aging-related cardiovascular diseases. Frontiers in Cell and Developmental Biology, 9, 641315.
Pietri, P., & Stefanadis, C. (2021). Cardiovascular Aging and Longevity: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 77(2), 189–204.
Krasniak, C. S., & Ahmad, S. T. (2016). The role of CHMP2BIntron5 in autophagy and frontotemporal dementia. Brain Research, 1649(Pt B), 151–157.
Feng, Q., Luo, Y., Zhang, X. N., Yang, X. F., Hong, X. Y., Sun, D. S., et al. (2020). MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: A vicious cycle in Alzheimer neurodegeneration. Autophagy, 16(4), 641–658.
Zaglia, T., Milan, G., Ruhs, A., Franzoso, M., Bertaggia, E., Pianca, N., et al. (2014). Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. Journal of Clinical Investigation, 124(6), 2410–2424.
Li, T., Yin, Y., Mu, N., Wang, Y., Liu, M., Chen, M., et al. (2021). Metformin-enhanced cardiac AMP-activated protein kinase/Atrogin-1 pathways inhibit charged multivesicular body protein 2b accumulation in ischemia–reperfusion injury. Frontiers in Cell and Developmental Biology, 8, 621509.
Korotkov, A., Seluanov, A., & Gorbunova, V. (2021). Sirtuin 6: Linking longevity with genome and epigenome stability. Trends in Cell Biology, S0962–8924(21), 00125–00132.
Khan, D., Ara, T., Ravi, V., Rajagopal, R., Tandon, H., Parvathy, J., et al. (2021). SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ. Cell Reports, 35(9), 109190.
Pillai, V. B., Samant, S., Hund, S., Gupta, M., & Gupta, M. P. (2021). The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy. Aging (Albany NY), 13(9), 12334–12358.
Grootaert, M., Finigan, A., Figg, N. L., Uryga, A. K., & Bennett, M. R. (2021). SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circulation Research, 128(4), 474–491.
Yu, L. M., Dong, X., Xue, X. D., Xu, S., Zhang, X., Xu, Y. L., et al. (2021). Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6. Journal of Pineal Research, 70(1), e12698.
Wang, X., Wang, X., Tong, M., Gan, L., Chen, H., Wu, S., et al. (2016). SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms. Basic Research in Cardiology, 111(2), 13.
Aghaei, M., Motallebnezhad, M., Ghorghanlu, S., Jabbari, A., Enayati, A., Rajaei, M., et al. (2019). Targeting autophagy in cardiac ischemia/reperfusion injury: A novel therapeutic strategy. Journal of Cellular Physiology, 234(10), 16768–16778.
Zhang, S., Jiang, S., Wang, H., Di, W., Deng, C., Jin, Z., et al. (2018). SIRT6 protects against hepatic ischemia/reperfusion injury by inhibiting apoptosis and autophagy related cell death. Free Radical Biology & Medicine, 115, 18–30.
Shi, M. Y., Bang, I. H., Han, C. Y., Lee, D. H., Park, B. H., & Bae, E. J. (2020). Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis. Theranostics, 10(25), 11416–11427.
Spurthi, K. M., Sarikhani, M., Mishra, S., Desingu, P. A., Yadav, S., Rao, S., et al. (2018). Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice. Journal of Biological Chemistry, 293(34), 13073–13089.
Hsu, C. P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., et al. (2010). Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation, 122(21), 2170–2182.
Peng, L., Qian, M., Liu, Z., Tang, X., Sun, J., Jiang, Y., et al. (2020). Deacetylase-independent function of SIRT6 couples GATA4 transcription factor and epigenetic activation against cardiomyocyte apoptosis. Nucleic Acids Research, 48(9), 4992–5005.
Huang, Z., Zhao, J., Deng, W., Chen, Y., Shang, J., Song, K., et al. (2018). Identification of a cellularly active SIRT6 allosteric activator. Nature Chemical Biology, 14(12), 1118–1126.
Yang, Y., Duan, W., Lin, Y., Yi, W., Liang, Z., Yan, J., et al. (2013). SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free radical biology & medicine, 65, 667–679.
Castillero, E., Alamdari, N., Lecker, S. H., & Hasselgren, P. O. (2013). Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Metabolism-Clinical and Experimental, 62(10), 1495–1502.
Li, C., Sun, W., Gu, C., Yang, Z., Quan, N., Yang, J., et al. (2018). Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility. Theranostics, 8(4), 1027–1041.
Zafir, A., Readnower, R., Long, B. W., McCracken, J., Aird, A., Alvarez, A., et al. (2013). Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells, 31(4), 765–775.
Zheng, J., Zhao, S., Yu, X., Huang, S., & Liu, H. Y. (2017). Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth. Theranostics, 7(5), 1373–1388.
Xu H, Yu W, Sun S, Li C, Ren J, Zhang Y. (2021). TAX1BP1 protects against myocardial infarction-associated cardiac anomalies through inhibition of inflammasomes in a RNF34/MAVS/NLRP3-dependent manner. Science Bulletin, 66(16), 1669–1683.
Li, Z., Zhang, H., Chen, Y., Fan, L., & Fang, J. (2012). Forkhead transcription factor FOXO3a protein activates nuclear factor kappaB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation. Journal of Biological Chemistry, 287(21), 17737–17745.
Mostoslavsky, R., Chua, K. F., Lombard, D. B., Pang, W. W., Fischer, M. R., Gellon, L., et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell, 124(2), 315–329.
Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., et al. (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature, 483(7388), 218–221.
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., et al. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117(3), 399–412.
Wang, D., Wang, Y., Zou, X., Shi, Y., Liu, Q., Huyan, T., et al. (2020). FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-gamma coactivator-1alpha-mediated mitochondrial biogenesis. British Journal of Pharmacology, 177(2), 432–448.
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., et al. (2020). Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation, 141(9), e139–e596.
Heusch, G. (2020). Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nature Reviews Cardiology, 17(12), 773–789.
Ma, H., Guo, R., Yu, L., Zhang, Y., & Ren, J. (2011). Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: Role of autophagy paradox and toxic aldehyde. European Heart Journal, 32(8), 1025–1038.
Wang, Y., Yang, Z., Zheng, G., Yu, L., Yin, Y., Mu, N., et al. (2019). Metformin promotes autophagy in ischemia/reperfusion myocardium via cytoplasmic AMPKα1 and nuclear AMPKα2 pathways. Life Sciences, 225, 64–71.
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018). The Role of autophagy in the heart. Annual Review of Physiology, 80, 1–26.
Li, Y., Liu, M., Song, X., Zheng, X., Yi, J., Liu, D., et al. (2020). Exogenous hydrogen sulfide ameliorates diabetic myocardial fibrosis by inhibiting cell aging through SIRT6/AMPK autophagy. Frontiers in Pharmacology, 11, 1150.
Acknowledgements
The authors wish to thank Dr Tian Li from the Fourth Military Medical University for his help in this research.
Funding
This study was financially supported by the National Natural Science Foundation of China (82070261, 91749108 to H. Ma; 81803053 and 82170251 to N. Mu), the Science and Technology Research and Development Program of Shaanxi Province, China (2018SF-270, 2015KW-050, 2018SF-101). The Youth Innovation Team of Shaanxi Universities (to H. Ma). The Seed Foundation of Innvation and Creation for Graduate Students in Northwestern Polytechnical University (CX202065 to Jiang WH).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics Approval
All the procedures in this study were in accordance with the Helsinki Declaration of 1975, as revised in 2000, and were approved by the ethical review board of Fourth Military Medical University (IACUC-20200602). Informed consents were obtained from all study participants. Institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
Conflict of Interest
The authors declare no competing interests.
Additional information
Associate Editor Junjie Xiao oversaw the review of this article
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, X., Liu, L., Jiang, W. et al. SIRT6 Protects Against Myocardial Ischemia–Reperfusion Injury by Attenuating Aging-Related CHMP2B Accumulation. J. of Cardiovasc. Trans. Res. 15, 740–753 (2022). https://doi.org/10.1007/s12265-021-10184-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-021-10184-y